Recurrent stroke and massive right-to-left shunt: Results from the prospective spanish multicenter (CODICIA) study

Stroke

Volumn 39, Issue 12, 2008, Pages 3131-3136

  Serena, Joaquín ^a   Marti Fàbregas, Joan ^b   Santamarina, Estevo ^c   Rodríguez, Juan Jesús ^d   Perez Ayuso, María Jesús ^a   Masjuan, Jaime ^e   Segura, Tomás ^f   Gállego, Jaime ^g   Dávalos, Antonio ^c  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^e Hospital Roman y Cajal   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^g Universidad Pública de Navarra   (Spain)

Author keywords

Cryptogenic stroke; Echocardiography; Patent foramen ovale; Transcranial Doppler

Indexed keywords

ACENOCOUMAROL; ACETYLSALICYLIC ACID; CONTRAST MEDIUM; FIBRINOLYTIC AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER ECHOGRAPHY; FEMALE; FOLLOW UP; FUNCTIONAL ASSESSMENT; HEART ANEURYSM; HEART RIGHT LEFT SHUNT; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATENT FORAMEN OVALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK FACTOR; STROKE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VALSALVA MANEUVER; AGE; BRAIN ISCHEMIA; CLINICAL TRIAL; COMORBIDITY; ECHOCARDIOGRAPHY; ECHOGRAPHY; MICROBUBBLE; MIDDLE AGED; MULTICENTER STUDY; PARADOXICAL EMBOLISM; PREVALENCE; SPAIN;

ADULT; AGE FACTORS; AGED; BRAIN ISCHEMIA; COMORBIDITY; CONTRAST MEDIA; ECHOCARDIOGRAPHY; EMBOLISM, PARADOXICAL; FEMALE; FIBRINOLYTIC AGENTS; FORAMEN OVALE, PATENT; HEART ANEURYSM; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MICROBUBBLES; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; SPAIN; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL; VALSALVA MANEUVER;

EID: 58149334924     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.108.521427     Document Type: Article

References (17)

1. Sacco RL, Ellenberg JH, Mohr JP, Tatemiechi TK, Hier DB, Price TR, Wolf PA. Infarcts of undetermined cause: the NINDS Stroke Data Bank. Ann Neurol. 1989;25:382-390.
2. Pearson AC, Nagelhout D, Castello R, Gomez CR, Labovitz A. Atrial septal aneurysm and stroke: a transesophageal echocardiographic study. J Am Coll Cardiol. 1991;18:1223-1229.
3. Lechat P, Mas JL, Lascault G, Loron P, Theard M, Klimczac M, Drobinski G, Thomas D, Grosgogeat Y. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med. 1998;318:1148-1152.
4. Di Tullio M, Sacco RL, Gopal A, Mohr JP, Homma S. Patent foramen ovale as a risk factor for cryptogenic stroke. Ann Intern Med. 1992;117: 461-465.
5. De Castro S, Cartoni D, Fiorelli M, Rasura M, Anzini A, Zanette EM, Beccia M, Colonnese C, Fedele F, Fieschi C, Pandian NG. Morphological and functional characteristics of patent foramen ovale and their embolic implications. Stroke. 2000;31:2407-2413.
6. Homma S, Di Tullio MR, Sacco RL, Mihalatos D, Li Mandri G, Mohr JP. Characteristics of patent foramen ovale associated with cryptogenic stroke: a biplane transesophageal study. Stroke. 1994;25:582-586.
7. Steiner MM, Di Tullio MR, Rundek T, Gan R, Chen X, Liquori C, Brainin M, Homma S, Sacco RL. Patent foramen ovale size and embolic brain imaging findings among patients with ischemic stroke. Stroke. 1998;29:944-948.
8. Serena J, Segura T, Perez-Ayuso MJ, Bassaganyes J, Molins A, Davalos A. The need to quantify right-to-left shunt in acute ischemic stroke: a case-control study. Stroke. 1998;29:1322-1328.
9. Jauss M, Zanette E, for the Consensus Conference. Detection of right-to-left shunt with ultrasound contrast agent and transcranial Doppler sonography. Cerebrovasc Dis. 2000;10:490-496.
10. Anzola GP, Zavarize P, Morandi E, Rozzini L, Parrinello G. Transcranial Doppler and risk of recurrence in patients with stroke and patent foramen ovale. Eur J Neurol. 2003;10:129-135.
11. Mas JL, Arquizan C, Lamy C, Zuber M, Cabanes L, Derumeaux G, Coste J, for the PFO and ASA study group. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med. 2001;345:1740-1746.
12. Homma S, Sacco RL, Di Tullio MR, Sciacca RR, Mohr JP; PFO in Cryptogenic Stroke Study (PICCS) Investigators. Effect of medical treatment in stroke patients with patent foramen ovale: Patent Foramen Ovale in Cryptogenic Stroke Study. Circulation. 2002;105:2625-2631.
13. Messe SR, Silverman IE, Kizer JR, Homma S, Zahn C, Gronseth G, Kasner SE. Quality Standards Subcommittee of the American Academy of Neurology: practice parameter: recurrent stroke with patent foramen ovale and atrial septal aneurysm: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2004; 62:1042-1050.
14. Khairy P, O'Donnell CP, Landzberg MJ. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med. 2003;139: 753-760.
15. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd. Classification of subtype of acute ischaemic stroke: definitions for use in a multicenter clinical trial. TOAST: trial of Org 10172 in acute stroke treatment. Stroke. 1993:24;2735.
16. Cote R, Battista RN, Wolfson C, Boucher J, Adam J, Hachinski V. The Canadian Neurological Scale: validation and reliability assessment. Neurology. 1989;39:638-643.
17. Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, Trystram D, Coste J, Mas JL. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Atrial Septal Aneurysm. Stroke. 2002;33:706-711.